Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
NBC New York

CONVERGE LIVE updates: Saleforce's Benioff talks tariffs; Alibaba's Tsai says AI not a competition between China and US

This was CNBC's live blog covering CONVERGE LIVE, an inaugural thought leadership event in Singapore. SINGAPORE — This was CNBC's live blog on Wednesday, March 12, the first day of CONVERGE LIVE in ...

Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...
Seeking Alpha

Converge's Aggressive M&A Announcements May Re-Ignite The Stock Price

Converge Technology Solutions Corp. offers digital storage services as well as different types of digital structures along with artificial intelligence services, and machine learning. I was quite ...